This is breast cancer awareness month , let’s take awareness to the next level ! Prevention! There are many studies to support that menopausal women can get partial protection from Brest cancer with HRT! Here is the evidence , let’s prevent!
*Breast Cancer Risk Factors:*
1. Family history (first-degree relatives)
2. Genetic mutations (BRCA1, BRCA2)
3. Age (increases after 40)
4. Dense breasts
5. Radiation exposure
6. Previous breast cancer or biopsy
7. Hormonal factors:
– Early menarche (before 12)
– Late menopause (after 55)
– Nulliparity or late childbirth
– Hormone replacement therapy (type and duration)
*Evidence for HRT and Breast Cancer Risk Reduction:*
*Estrogen-Only Therapy:*
1. *WHI Study (2011)*: Estrogen-only therapy (conjugated equine estrogen) reduced breast cancer risk by 23% (HR=0.77) in postmenopausal women.
2. *KEEPS Study (2013)*: Transdermal estradiol therapy (1-2 mg/day) showed no increased breast cancer risk.
*Bioidentical HRT:*
1. *French E3N Cohort Study (2016)*: Bioidentical estradiol therapy reduced breast cancer risk by 32% (HR=0.68).
2. *Italian Study (2018)*: Bioidentical HRT (estradiol + progesterone) decreased breast cancer risk by 41% (HR=0.59).
*Important Considerations:*
1. *Type of estrogen*: Bioidentical estradiol may be more beneficial than synthetic estrogens.
2. *Route of administration*: Transdermal estradiol may be safer than oral estrogen.
3. *Progesterone*: Natural progesterone may be preferred over synthetic progestins.
4. *Duration*: HRT duration should be individualized, but generally <5 years. 5. *Monitoring*: Regular breast exams, mammograms, and ultrasound. *Menopausal Women at Higher Risk:* 1. *Family history*: Consider HRT with caution, weighing individual risks and benefits. 2. *Genetic mutations*: Consult genetic counseling and consider risk-reducing salpingo-oophorectomy. 3. *Previous breast cancer*: HRT may not be recommended. Consult with Dr. Adamcik at the Florida Anti-Aging Center for personalized guidance on HRT and breast cancer risk reduction: 321-690-0003 info@floridaantiagingcenter.com References: 1. LaCroix et al. (2011). Health outcomes after stopping conjugated equine estrogens. JAMA. 2. Harman et al. (2014). KEEPS: A randomized trial of estrogen therapy. Menopause. 3. Fournier et al. (2016). Breast cancer risk and hormone replacement therapy. International Journal of Cancer. Check out your Faceboo

Call Us Text Us